NorthX Biologics Secures Significant Growth Investment from Signet Healthcare Partners
May 20, 2025
NorthX Biologics, a leading Nordic biopharmaceutical Contract, Development and Manufacturing Organization, is pleased to announce a significant growth investment from Signet Healthcare Partners, a U.S.-based